New survey reveals men would rather sit in traffic than talk about prostate health
Reports and Proceedings
Updates every hour. Last Updated: 4-Nov-2025 18:11 ET (4-Nov-2025 23:11 GMT/UTC)
Investigators from Mass General Brigham have developed a way to promote antitumor immunity by hijacking cellular machinery within cancer cells. The study demonstrated that inducing cancer cells to produce an immune-activating molecule led to reduced tumor growth in preclinical models. Results are published in PNAS.
“Tumor cells comprise a significant proportion of the tumor microenvironment but are often under-utilized for immunotherapy,” said corresponding author Natalie Artzi, PhD, a researcher in the Mass General Brigham Department of Medicine. “These findings highlight how tumor cells can be used to actively contribute to their own elimination.”
A new study found that firefighters exposed to the Palisades and other fires had changes in their immune system and inflammatory response protein pathways.
By activating an immune signaling pathway inside cancer cells, MIT researchers found a way to force tumors to produce a molecule that leads to their own destruction.
Unnaturally repeating copies of genetic code called tandem duplications within the UBTF gene lead to a high-risk form of acute myeloid leukemia, UBTF-TD AML, which is known for treatment resistance and relapse. Researchers found that these copies give rise to an anomalous transport signal not found in the naturally occurring UBTF protein.
The Alliance for Clinical Trials in Oncology has launched a new clinical trial seeking to evaluate the feasibility of delivering a structured exercise program entirely through telehealth for patients with cancer receiving chemotherapy with the ultimate goal of reducing fatigue and disability. The DEFEND (distance-based exercise to preserve function and prevent disability), trial (Alliance A222302) aims to enroll participants between the ages of 18 and 65 who are receiving chemotherapy with curative intent. The study will assess whether virtual exercise sessions, consisting of supervised resistance and aerobic exercise training, can successfully be delivered to patients during treatment. The study will also explore whether the exercise program can help patients maintain physical function, reduce fatigue and prevent disability during treatment, providing critical data to inform the design of a subsequent phase III trial powered to evaluate the impact of exercise on these outcomes.